These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9472211)

  • 21. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
    Halsos AM
    Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate at the knee joint on the hypothalamic-pituitary-adrenal axis: a case-controlled study.
    Habib G; Artul S; Chernin M; Hakim G; Jabbour A
    J Investig Med; 2013 Oct; 61(7):1104-7. PubMed ID: 24013525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic effects of local treatment with high doses of potent corticosteroids in psoriatics.
    Nilsson JE; Gip LJ
    Acta Derm Venereol; 1979; 59(3):245-8. PubMed ID: 87083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal suppression with intranasal betamethasone drops.
    Flynn MD; Beasley P; Tooke JE
    J Laryngol Otol; 1992 Sep; 106(9):827-8. PubMed ID: 1431525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of treatment and adrenal cortex function in patients with bronchial asthma after long-term use of depot betamethasone].
    Droszcz W; Piotrowska B
    Pol Arch Med Wewn; 1984 Dec; 72(6):287-91. PubMed ID: 6535149
    [No Abstract]   [Full Text] [Related]  

  • 26. Betamethasone abuse in infancy.
    Adhisivam B; Mahadevan S
    Indian Pediatr; 2005 Apr; 42(4):396-7. PubMed ID: 15876610
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
    Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
    J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic toxicity of topical corticosteroids.
    Jinagal J; Gupta PC; Pilania RK; Ram J
    Indian J Ophthalmol; 2019 Apr; 67(4):559-561. PubMed ID: 30900600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cushing's syndrome induced by local corticoid therapy].
    Leblac A; Choulot JJ
    Nouv Presse Med; 1978 May; 7(21):1857. PubMed ID: 673740
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
    Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
    Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
    Ridgway HB; Moriello KA
    Arch Dermatol; 1993 Mar; 129(3):379. PubMed ID: 8447682
    [No Abstract]   [Full Text] [Related]  

  • 32. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
    Katz HI; Hien NT; Prawer SE; Mastbaum LI; Mooney JJ; Samson CR
    J Am Acad Dermatol; 1987 Apr; 16(4):804-11. PubMed ID: 3553247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal iatrogenic Cushing's syndrome.
    Nathan AW; Rose GL
    Lancet; 1979 Jan; 1(8109):207. PubMed ID: 84219
    [No Abstract]   [Full Text] [Related]  

  • 34. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient.
    Kedem E; Shahar E; Hassoun G; Pollack S
    J Asthma; 2010 Sep; 47(7):830-1. PubMed ID: 20653496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide.
    Jones W; Chastain CA; Wright PW
    Pharmacotherapy; 2014 Jul; 34(7):e116-9. PubMed ID: 24757038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of exogenous Cushing's syndrome due to unlicensed medications.
    Azizi F; Jahed A; Hedayati M; Lankarani M; Bejestani HS; Esfahanian F; Beyraghi N; Noroozi A; Kobarfard F
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):921-5. PubMed ID: 18462262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cushing's syndrome caused by topical administration of betamethasone].
    Anglada J; Sánchez P; Torras R
    Med Clin (Barc); 1986 Jan; 86(1):40. PubMed ID: 3959630
    [No Abstract]   [Full Text] [Related]  

  • 38. Adrenal function during topical oral corticosteroid treatment.
    Lehner T; Lyne C
    Br Med J; 1969 Oct; 4(5676):138-41. PubMed ID: 4309863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal effects and serum cortisol levels after multiple courses of maternal corticosteroids.
    Terrone DA; Smith LG; Wolf EJ; Uzbay LA; Sun S; Miller RC
    Obstet Gynecol; 1997 Nov; 90(5):819-23. PubMed ID: 9351771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient.
    Tsoukas MA; Krishnamoorthy P; Richards BJ; Pepe C; Christopoulos S
    Am J Med; 2014 May; 127(5):e1-2. PubMed ID: 24412770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.